What Conditions Mimic Myasthenia Gravis?

A surprisingly wide range of conditions can look like myasthenia gravis, and telling them apart is one of the trickier problems in neurology. A large retrospective study at two Italian tertiary centers found that among patients initially suspected of having seronegative MG, over a third ultimately turned out to have something else entirely.¹ The mimics span thyroid disease, inherited muscle disorders, autoimmune nerve conditions, brain lesions, drug side effects, and even psychiatric-spectrum disorders. Getting the diagnosis right matters because the treatments for these conditions diverge sharply, and a wrong label can mean years of ineffective or harmful therapy.

Why Myasthenia Gravis Is So Easy to Imitate

MG is the most common chronic autoimmune disorder of the neuromuscular junction, affecting the point where nerve signals tell muscles to contract. In at least four out of five people with the generalized form, the immune system produces antibodies against acetylcholine receptors on the muscle side of that junction.² The resulting symptoms, drooping eyelids, double vision, difficulty swallowing, and limb weakness that worsens with use, are not unique to MG. Any disease that weakens the same muscle groups or causes fatigue-like fluctuation can look strikingly similar at the bedside. And because a subset of MG patients have no detectable antibodies at all (so-called seronegative MG), blood tests alone cannot always settle the question.³

Thyroid Eye Disease

Thyroid-associated orbitopathy, sometimes called Graves’ ophthalmopathy, is probably the single most confusing ocular mimic. Both conditions cause double vision, restricted eye movements, and eyelid abnormalities. The overlap is so convincing that when thyroid eye disease and ocular MG actually coexist in the same person, clinicians can miss the MG entirely because the thyroid problem seems to explain everything.⁴ The Italian retrospective study also identified Basedow-Graves ophthalmopathy as one of the leading alternative diagnoses in patients wrongly suspected of MG.¹

A key clinical difference is that thyroid eye disease tends to cause eye-movement limitation from inflamed, swollen eye muscles that restrict mechanically, while MG weakens the muscles so they cannot contract fully. Imaging of the eye socket usually settles it: enlarged muscles on a CT or MRI scan point toward thyroid disease. But in early or mild cases, the imaging can be equivocal, and both conditions can fluctuate day to day, making the clinical picture muddier than it should be.

Lambert-Eaton Myasthenic Syndrome

Lambert-Eaton myasthenic syndrome targets the same junction between nerve and muscle that MG does, but at the opposite side of the gap. Instead of antibodies attacking receptors on the muscle, LEMS involves antibodies against voltage-gated calcium channels on the nerve terminal, reducing the release of the chemical signal. Both diseases cause weakness that can affect the limbs and occasionally the eyes, but LEMS tends to hit the legs first and classically improves briefly with repeated muscle use, the opposite of MG’s pattern. It has also been long recognized that standard nerve-stimulation tests used to confirm a neuromuscular junction problem can overlap between the two conditions, making electrophysiology alone sometimes insufficient to distinguish them.⁵

LEMS deserves attention for another reason: roughly half of cases are paraneoplastic, meaning they are triggered by an underlying cancer, most often small-cell lung cancer. A person diagnosed with “MG” who does not respond to standard MG therapy should be re-evaluated for LEMS, because the cancer screening that follows could be life-saving.

Congenital Myasthenic Syndromes

Congenital myasthenic syndromes are genetic conditions caused by mutations that impair signaling at the neuromuscular junction. They can affect structures on either the nerve side or the muscle side of the synapse and result in muscle weakness that often begins in infancy or childhood.⁶ Because the symptoms, droopy lids, difficulty feeding, limb weakness, look like a childhood-onset form of MG, these patients are sometimes started on immunosuppressive drugs meant for autoimmune MG. Those drugs do nothing for a genetic defect, and the correct treatment varies depending on the specific mutation. In some subtypes the standard MG drug pyridostigmine helps, but in others it can actually make the condition worse.

The distinction usually becomes clear once antibody testing comes back negative and genetic testing identifies a causative mutation. But in countries or settings where genetic panels are not readily available, the misdiagnosis can persist for years.

Progressive External Ophthalmoplegia and Oculopharyngeal Muscular Dystrophy

Two inherited muscle conditions deserve their own mention because they closely mimic the ocular and bulbar features of MG. Progressive external ophthalmoplegia is a clinical syndrome defined by slowly worsening droopy lids and impaired eye movements. It encompasses an expanding set of genetically distinct subtypes, many linked to mitochondrial DNA problems.⁷ Because PEO develops gradually and affects the same muscles MG commonly targets, it can be mistaken for a slowly progressive form of MG, especially when antibody tests are borderline or when the patient has not yet undergone genetic workup.

Oculopharyngeal muscular dystrophy presents with droopy eyelids and swallowing difficulty, a combination that maps almost perfectly onto the bulbar presentation of MG. Published case reports describe patients with OPMD who also tested positive for acetylcholine receptor antibodies, meaning the two conditions genuinely coexisted, adding yet another layer of diagnostic confusion.⁸ Even neurophysiological testing can overlap between them.⁹ One useful clue: OPMD typically appears in middle age, progresses in a steady fashion rather than fluctuating, and often runs in families with a recognizable dominant inheritance pattern.

Miller Fisher Syndrome

Miller Fisher syndrome is a variant of Guillain-Barré syndrome, the acute autoimmune condition that attacks peripheral nerves. The classic triad includes eye-movement paralysis, poor coordination, and absent reflexes. Because the eye-movement problems look so much like ocular MG, initial misdiagnosis is well documented. In one reported case, a patient with MFS was started on MG medication, and only when the drug failed to improve symptoms did testing for the anti-GQ1b antibody reveal the real diagnosis.¹⁰

The distinction matters clinically because MFS usually resolves on its own over weeks, sometimes with the help of intravenous immunoglobulin, whereas MG requires long-term immunosuppression. Missing MFS and treating with pyridostigmine wastes time and delays recovery monitoring. A helpful clue is that MFS tends to come on acutely, often days after a viral infection, while ocular MG usually develops more gradually.

Motor Neuron Disease and Brain Stem Lesions

Motor neuron diseases, including amyotrophic lateral sclerosis, can occasionally be confused with MG, especially when the initial symptoms are bulbar: slurred speech, difficulty swallowing, tongue weakness. A published case report described a 50-year-old man with MG who was wrongly diagnosed with motor neuron disease, leading to inappropriate treatment decisions.¹¹ The confusion can go in either direction: MG mistaken for MND, or MND mistaken for MG. Because MND carries a far grimmer prognosis, getting this right has enormous implications for both treatment planning and patient counseling.

Brain stem masses can also mimic MG in both clinical appearance and even electrophysiology. A case report documented a brain stem lesion in a 38-year-old woman who not only had symptoms resembling MG but also showed a decremental response on repetitive nerve stimulation, the very electrical test used to support an MG diagnosis.¹² That finding is a humbling reminder that even electrophysiological tests, which are considered fairly specific, have limits. Brain imaging should be part of the workup whenever the clinical picture does not add up neatly.

Inflammatory Myopathies

Inflammatory muscle diseases such as polymyositis and dermatomyositis can mimic the proximal weakness and fatigue of generalized MG. In a case series studying patients with both myositis and MG, the overlap was striking: the vast majority had bulbar weakness, and most reported the kind of fatigable weakness that is considered a hallmark of MG.¹³ In some of those patients, the standard MG drug pyridostigmine actually improved symptoms, further blurring the diagnostic line. In inflammatory myopathies, muscle enzymes like creatine kinase are typically elevated, which provides one biochemical distinction, though CK can occasionally be mildly elevated in MG as well.

Functional Neurological Disorders

Perhaps the most unexpected finding from the Italian retrospective study was that functional disorders were the single most common alternative diagnosis in patients suspected of having seronegative MG, accounting for nearly half of all mimics identified.¹ Functional neurological disorder involves real, disabling symptoms that arise from abnormal nervous system function rather than structural damage or autoimmunity. Patients can present with weakness, droopy eyelids, or speech difficulty that fluctuates in ways that superficially resemble MG’s pattern of fatigability.

Distinguishing functional disorders from MG requires careful examination: positive signs of functional weakness (such as inconsistent effort on testing, or Hoover’s sign where hip flexion normalizes when attention is directed elsewhere) help, but the diagnosis is often one of exclusion. The study also found that patients ultimately diagnosed with MG mimics, including functional disorders, tended to have longer delays before reaching the correct diagnosis and a higher prevalence of psychiatric disorders compared to those with confirmed MG.

Drug-Induced MG-Like Symptoms

A growing number of medications can interfere with neuromuscular transmission and produce symptoms that look like MG. Immune checkpoint inhibitors used in cancer treatment are the best-known culprits; they can trigger genuine autoimmune MG by unleashing the immune system. But subtler drug-induced mimicry also occurs. A case report documented a patient who developed MG-like symptoms after starting galcanezumab, a monoclonal antibody used for migraine prevention, suggesting that the drug affected the neuromuscular junction.¹⁴

Other drugs historically linked to MG-like weakness or to unmasking subclinical MG include certain antibiotics (aminoglycosides, fluoroquinolones), beta-blockers, magnesium infusions, and botulinum toxin injections. In the case of botulinum toxin, the mechanism is straightforward: the toxin blocks acetylcholine release at the junction, the same basic problem that occurs in LEMS. A patient who receives cosmetic or therapeutic Botox injections can develop droopy eyelids with a fluctuating pattern that looks remarkably like ocular MG and can even produce a positive result on the ice test, a bedside tool normally considered fairly specific for MG.¹⁵

How Doctors Sort Through the Mimics

No single test rules MG in or out definitively, and the diagnostic process typically involves layering several tools. Antibody testing is the most straightforward first step: acetylcholine receptor antibodies are found in the majority of generalized MG cases, and when present, they essentially confirm the diagnosis. But a significant minority of MG patients are seronegative, meaning they test negative for both AChR and MuSK antibodies. Several factors can contribute to this, including lab inaccuracies, low antibody production, prior immunosuppressive therapy, and immune senescence in older patients.³

Electrophysiology fills in where blood tests leave off. Repetitive nerve stimulation and single-fiber electromyography are the two main techniques. In a real-world study comparing confirmed MG patients to those with mimics, both groups could show abnormal findings on single-fiber EMG, but people with MG had significantly higher jitter values and a greater percentage of abnormal fiber pairs. Repetitive nerve stimulation was abnormal in about a quarter of MG patients and was more strongly associated with generalized rather than purely ocular disease.¹⁶ These tests are helpful but imperfect: as noted earlier, even brain stem lesions can produce a decremental pattern on repetitive nerve stimulation, and some myopathies can mimic jitter abnormalities.

At the bedside, the ice pack test offers a low-tech screening tool. Applying an ice pack to a droopy eyelid for several minutes and measuring the improvement can help distinguish MG from other causes of ptosis. In one study, the test achieved roughly 93% sensitivity for myasthenic ptosis and over 98% specificity, though specificity dropped when the test was applied to double vision rather than eyelid droop.¹⁷ The ice test works because cooling slows the breakdown of acetylcholine at the junction, temporarily compensating for the receptor deficit in MG. Patients with Horner syndrome or oculomotor nerve palsy do not improve with ice, which helps exclude those conditions. But as mentioned, botulinum toxin-related ptosis can also respond to ice, so context matters.

The Cost of a Wrong Diagnosis

Misidentifying a mimic as MG, or vice versa, carries real consequences. A retrospective case series focused on chronic mimics found that the average duration of misdiagnosis was about nine years, with a median of eleven years. Every patient in the series had been placed on anticholinesterase therapy, several had received immunosuppressive drugs, and three had undergone surgical procedures including two thymectomies, all for a disease they did not have.¹⁸ Thymectomy is a legitimate treatment for MG linked to thymic abnormalities, but performing it on someone with oculopharyngeal muscular dystrophy or a functional disorder provides no benefit and adds surgical risk.

The reverse error, missing MG and diagnosing something else, is equally dangerous. One documented case involved a 12-year-old boy whose MG was initially mistaken for complications of meningitis and later for critical illness neuropathy, resulting in nearly a decade of morbidity before the correct diagnosis was made.¹⁹ MG is a treatable disease, and modern immunotherapy can put most patients into remission or near-remission. Every year of missed diagnosis is a year of unnecessary disability.

When Conditions Genuinely Coexist

One of the most confounding scenarios is when a mimic condition is not merely mimicking MG but actually occurring alongside it. Autoimmune diseases tend to cluster, and MG patients have higher-than-expected rates of other autoimmune conditions such as thyroid disease. When thyroid eye disease and ocular MG coexist in the same patient, the thyroid problem can mask the MG component, leaving half the problem untreated.⁴

OPMD and MG have been reported together in the same individual, with acetylcholine receptor antibodies confirming the autoimmune component alongside genetic confirmation of the dystrophy.⁸ Similarly, inflammatory myopathies and MG can overlap, with patients showing features of both muscle inflammation and neuromuscular junction dysfunction.¹³ These overlap cases are rare, but they serve as a reminder that finding one diagnosis does not always mean the search is over. When a patient with a confirmed alternative diagnosis fails to respond fully to appropriate therapy, revisiting the possibility of coexistent MG is reasonable.

Benign Essential Blepharospasm and Refractive Errors

Not every MG mimic is a dramatic neuromuscular or autoimmune condition. In the Italian cross-sectional study, benign essential blepharospasm and simple refractive errors were both among the alternative diagnoses found in patients referred for possible MG.¹ Blepharospasm causes involuntary eyelid closure that can look like the droopy lids of MG to the untrained eye, though the mechanism is completely different: the eyelids are being squeezed shut by overactive muscles rather than dropping because of weak ones. Refractive errors causing visual strain and intermittent double vision can also prompt referral to a neuromuscular specialist if the primary care provider suspects a neurological cause. These benign mimics are a reminder that the differential diagnosis of “possible MG” extends well beyond rare neuromuscular diseases and into everyday ophthalmology.

1
PubMed. Double seronegative myasthenia gravis and mimics: a retrospective cross-sectional study by two tertiary centers in the Southern Italy
2
PubMed. Correlation between acetylcholine receptor antibody levels and thymic pathology in myasthenia gravis: a review
3
PubMed Central. Diagnosis and Management of Seronegative Myasthenia Gravis: Lights and Shadows
4
PubMed Central. Rare Co-occurrence of Ocular Myasthenia Gravis and Thyroid-Associated Orbitopathy (Ophthalmopathy) in an Individual With Hypothyroidism
5
Arquivos de Neuro-Psiquiatria. Low frequency repetitive stimulation as a tool to differentiate Eaton-Lambert myasthenic syndrome from myasthenia gravis
6
PubMed. Myasthenia gravis and congenital myasthenic syndromes
7
PubMed Central. Progressive external ophthalmoplegia
8
PubMed. Oculopharyngeal muscular dystrophy coexisting with myasthenia gravis
9
PubMed. Oculopharyngeal muscular dystrophy, myasthenia gravis, systemic lupus erythematosus: overlap and interactions
10
PubMed Central. Miller Fisher syndrome mimicking ocular myasthenia gravis
11
PubMed Central. Life-threatening misdiagnosis of bulbar onset myasthenia gravis as a motor neuron disease
12
PubMed. Brain stem lesion mimicking myasthenia gravis
13
PubMed Central. The Co-Existence of Myasthenia Gravis in Patients with Myositis: A Case Series
14
Cureus. Galcanezumab-Induced Myasthenia Gravis-Like Symptoms
15
PubMed. Variable ptosis after botulinum toxin type a injection with positive ice test mimicking ocular myasthenia gravis
16
PubMed. Electrophysiologic evaluation of myasthenia gravis and its mimics: real-world experience with single-fiber electromyography
17
PubMed. The ice pack test in the differential diagnosis of myasthenic diplopia
18
PubMed. Chronic mimics of myasthenia gravis: a retrospective case series
19
PubMed Central. Misdiagnosis of Myasthenia Gravis and Subsequent Clinical Implication: A case report and review of literature